Page last updated: 2024-09-03

bw a868c and 9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin d2

bw a868c has been researched along with 9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin d2 in 1 studies

Compound Research Comparison

Studies (bw a868c)	Trials (bw a868c)	Recent Studies (post-2010) (bw a868c)	Studies (9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin d2)	Trials (9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin d2)	Recent Studies (post-2010) (9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin d2)
47	0	11	51	0	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abramovitz, M; Ford-Hutchinson, AW; Metters, KM; Wright, DH	1

Other Studies

1 other study(ies) available for bw a868c and 9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin d2

Article	Year
Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. British journal of pharmacology, 1998, Volume: 123, Issue:7 Topics: Adenine Nucleotides; Benzoates; Binding, Competitive; Cell Line; Cyclic AMP; Dinoprostone; Guanine Nucleotides; Humans; Kinetics; Receptors, Immunologic; Receptors, Prostaglandin; Recombinant Proteins; Thiazoles; Thiazolidines; Tritium	1998

Article

Year

Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist.

British journal of pharmacology, 1998, Volume: 123, Issue:7

Topics: Adenine Nucleotides; Benzoates; Binding, Competitive; Cell Line; Cyclic AMP; Dinoprostone; Guanine Nucleotides; Humans; Kinetics; Receptors, Immunologic; Receptors, Prostaglandin; Recombinant Proteins; Thiazoles; Thiazolidines; Tritium

1998